Alternatives to EyePoint Pharmaceuticals
EyePoint Pharmaceuticals is a Biotechnology tool: ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
EyePoint Pharmaceuticals profileMore Biotechnology alternatives
The 20 closest Biotechnology companies to EyePoint Pharmaceuticals
- Website
Ray Therapeutics53BiotechnologyBerkeley, USA$243.0MPioneering vision restoration therapies for severe retinal degenerations.
- Website
Tarsier Pharma47HealthcareTel Aviv, Israel$5.0MClinical-stage company developing novel treatments for ocular inflammatory blinding diseases.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website
Spiderwort55BiotechnologyOttawa, Canada$16.2MBiotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.
- Website
Verdiva Bio54BiotechnologySan Diego, United States$170.0MClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
- Website
SonoThera53BiotechnologySan Francisco, USA$125.0MDeveloping ultrasound-mediated nonviral genetic medicines.
- CECellbricks Therapeutics53BiotechnologyBerlin, Germany$7.0M
Biofabrication platform for 3D-printed human tissue implants and future organ manufacturing.
- Website
Element Biosciences53BiotechnologySan Diego, USA$175.0MRevolutionizing genomic analysis with innovative sequencing technology.
- Website SCScience52BiotechnologySan Francisco, USA$230.0M
Developing advanced vision restoration technology through a retinal implant.
- CECellply52BiotechnologyBologna, Italy$7.2M
DeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.
- Website
En Carta Diagnostics52BiotechnologyParis, France$5.0MDeveloping a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.
- Website
Fibionic51BiotechnologyParis, France$6.0MDeveloping lightweight bionic technology.
- Website
ONWARD Medical50BiotechnologyEindhoven, Netherlands$171.2MNeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.
- Website
Cognito Therapeutics50BiotechnologyBoston, USA$213.0MDeveloping a novel therapeutic approach for Alzheimer's disease.
- Website
Surf Therapeutics50BiotechnologyAustin, United States$6.0MDeveloping non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.
- Website
TIXiMED49BiotechnologyBirmingham, United States$4.8MClinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.
- Website
Neurosoft Bioelectronics49BiotechnologyGeneva, Switzerland$7.5MDeveloping soft, stretchable brain-computer interface platforms.
- Website COContraline48BiotechnologyCharlottesville, USA$102.5M
Developing novel male contraceptives.
- Website SCScinus Group47BiotechnologyUtrecht, Netherlands$3.0M
Develops and distributes bioreactor technology for stem cell cultivation.
Showing the 20 closest matches. See the rest on the EyePoint Pharmaceuticals profile.
Compare EyePoint Pharmaceuticals head to head
Side by side on what each one does, what it costs, and what real users report.